Physician profile
Jonathan D Baum
NPI 1760421978
$568.09
in general payments reported to CMS, 2019-2025
17 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $57.48 · 2021: $14.13 · 2022: $89.05 · 2023: $62.27 · 2024: $34.17 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $119.32 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $76.91 | 2019-2025 | |
| Organon LLC | $66.61 | 2022-2024 | Nexplanon |
| Evofem Biosciences, INC. | $47.78 | 2022-2025 | Phexxi, Solosec, Phexx |
| Davol INC. | $36.79 | 2020 | |
| Abbvie INC. | $31.93 | 2022 | |
| Duchesnay USA Incorporated | $27.62 | 2019 | |
| Mayne Pharma Commercial LLC | $22.92 | 2023-2025 | |
| Pfizer INC. | $18.68 | 2023 | |
| Bard Access Systems, INC. | $16.87 | 2019 | |
| Exeltis, USA INC. | $16.83 | 2023 | Slynd |
| Hologic Sales and Service, LLC | $15.97 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.00 | 2019 | |
| Merck Sharp & Dohme LLC | $14.12 | 2019 | |
| Therapeuticsmd, INC. | $13.83 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $13.69 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Baum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.